Justin Onclin in front of his wine chateau

Justin Onclin: From Vine to Real Estate, an Empire of 49 Million Euros

Justin Onclin, a leading figure in the Belgian wine industry, has diversified his investments to build a fortune of over 43 million euros. Founder of Sovex in 1981 and owner of prestigious wine châteaux in Bordeaux, Onclin has also extended his influence to the real estate sector, with major projects such as Stadshaven in Hasselt. Under the leadership of his children, the Onclin family continues to prosper and diversify its assets, testifying to Justin Onclin's strategic vision in creating a lasting legacy.

The 3 Janssen heirs of the UCB management family

The Janssen Family Dynasty: Secular Influence and a 3-Billion-Euro Fortune

The Janssen family, one of Belgium's most influential dynasties, has positioned itself at the heart of the banking, industrial and pharmaceutical sectors. With assets estimated at over 3 billion euros, their legacy is marked by strategic alliances, notably with the Solvay group and UCB, and by rigorous management of their assets. From Daniel Janssen to Charles-Antoine Janssen, each generation has strengthened the family's grip on the Belgian economy. Discover how this family has combined tradition, innovation and strategy to become one of Belgium's wealthiest.

Emsens family pre-certification of designer stanislals

Emsens family: a Belgian dynasty with assets worth 2.6 billion euros

The Emsens family, ranked among the 14 richest families in Belgium, controls an industrial empire with companies such as SCR-Sibelco, Aliaxis and Etex. These multinationals, specializing in sand mining, construction products and materials such as asbestos cement, reinforce the Emsens' influence on the global market. With assets of over 2.6 billion euros, the Emsens family is also extending its influence through strategic investments in companies such as Sofina and Solvay, consolidating their position as one of Belgium's leading industrial dynasties.

photo by Dr. Paul Janssen

Dr. Paul Janssen: The Visionary Entrepreneur Behind a 300 Million Euro Fortune and a Pharmaceutical Legacy

Dr. Paul Janssen, founder of Janssen Pharmaceutica, is one of the most influential figures in the Belgian pharmaceutical industry. With a legacy estimated at over 300 million euros, Janssen revolutionized medicine with innovative medicines, while remaining a central figure in the company after its takeover by Johnson & Johnson. In addition to his medical contributions, he left a significant cultural imprint, with a unique collection of pre-Columbian art. Discover how this visionary built a pharmaceutical empire while influencing Belgian art and economics.

Photo of the Emsens family with a blue book

Emsens family: 1.1 billion euros and a deep industrial heritage in sand mining

The Emsens family, pillars of the SCR-Sibelco group, have fashioned an industrial empire centered on the extraction of quartz sand used in glass production. With assets estimated at 1.1 billion euros, SCR-Sibelco is a little-known but key player in the global mining industry. Their influence extends across Europe, the United States and Mexico, while navigating contemporary challenges such as subsidiary restructuring and global market fluctuations. Discover how this Belgian dynasty continues to influence the economy while adapting to new realities.

Alexandre van damme produced the 2 beers

Alexandre Van Damme: From Family Inheritance to a 10 Billion Euro Fortune

Alexandre Van Damme, heir to a long Belgian brewing tradition, has transformed the small family brewery into a global giant, AB InBev. With an estimated fortune of over 10 billion euros, he is the second-richest Belgian. Renowned for his strategic vision and discreet leadership, Van Damme has diversified his investments into global companies such as Kraft Heinz and Douwe Egberts, while remaining a key figure in the beverage industry. Find out how Alexandre combined family tradition and innovation to become a key figure in the business world.

Fabri family catchou plantation with a black man cutting

The Fabri Dynasty: A Major and Controversial Influence with a Fortune of 350 Million Euros

The Fabri family, rooted in the banking and plantation sectors, is an influential and controversial Belgian dynasty. Founded by financiers such as Charles Fabri, it has weathered financial and political scandals while building an empire estimated at over 300 million euros. Under the leadership of Hubert Fabri, the family has navigated between economic success and legal wrangling, not least thanks to strategic alliances with the likes of Vincent Bolloré. Find out how the Fabri family has maintained its influence and wealth despite the challenges.

Building the Willemen family

Willemen family: the 750-million-euro construction empire undergoing a metamorphosis

The Willemen family, at the head of a construction empire estimated at 750 million euros in annual sales, is navigating through a crucial period of transformation. Founded by Johan Willemen, the Willemen Group has established itself as a construction giant in Belgium, with over 2,100 employees. Despite recent challenges, including a loss of 35 million euros in 2022, the company is demonstrating its resilience by refocusing on the Belgian market. With a family fortune in excess of 53 million euros, the Willemen are a perfect example of how a family business can adapt to the turbulence of the construction sector, while maintaining its leading position in key areas such as infrastructure and real estate.

woman of color analyzing the Medina laboratory of Famille De Raedt-Verheyden

De Raedt-Verheyden family: Colossal 1.7-billion-euro empire in biotechnology

Gino De Raedt and Frederica Verheyden have built a financial empire estimated at over 1.7 billion euros, from a simple medical laboratory in 1978 to major players in European biotechnology. Their journey, marked by strategic acquisitions and a spectacular merger with Biogroup, illustrates an exceptional entrepreneurial vision. With record dividends and diversified investments in real estate and private equity, the De Raedt-Verheyden couple have become one of Belgium's largest fortunes, while preparing for the future with their daughter Ann. Their story embodies the perfect blend of scientific innovation and financial genius.